State Street Corp Cytokinetics Inc Call Options Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
400Shares Held
128MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$546 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$441 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$370 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$297 Million0.06% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.07MShares$114 Million4.32% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.5B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...